Home > Healthcare > Biotechnology > Bioservices > Multi-omics Market

Multi-omics Market Share

Report ID: GMI7517
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Multi-omics Market Share

The market is characterized by diverse players competing in the industry. Becton, Dickinson and Company, Thermo Fisher Scientific Inc., and Illumina, Inc. account for significant market share. These prominent players thrive through a combination of strategic initiatives, investing in research and development, geographical expansion, strategic approaches, product diversification, and regulatory compliance. The foremost market players operating in the multi-omics industry is as mentioned below:

Becton, Dickinson and Company
Thermo Fisher Scientific Inc.
Illumina, Inc
Danaher
PerkinElmer Inc.
Shimadzu Corporation
Bruker
QIAGEN
Agilent Technologies, Inc.
BGI
10x Genomics
CYTENA GmbH

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global multi-omics industry was valued at USD 2.9 billion in 2022 and is estimated to grow at a CAGR of 15.2% between 2023 and 2032, owing to the continuous evolution and refinement of omics technologies.

The oncology application is poised to reach USD 3.3 billion by 2032, as the integration of genomics, transcriptomics, proteomics, and metabolomics has allowed researchers and clinicians to unravel the complex landscape of cancer at a molecular level, paving the way for more targeted therapies.

North America market accounted for a revenue share of 46.8% in 2022 and will showcase high growth rate through 2032, attributed to substantial investments in R&D, a robust infrastructure for healthcare innovation, and a proactive regulatory environment fostering the adoption of multi-omics approaches.

Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Illumina, Inc, Danaher, PerkinElmer Inc., Shimadzu Corporation, Bruker, QIAGEN, Agilent Technologies, Inc., and BGI among others.